Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
This study is ongoing, but not recruiting participants.
Study NCT01081730 Information provided by Janssen Biotech, Inc.
First Received on March 4, 2010. Last Updated on May 7, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Skin Diseases, Papulosquamous
Interventions listed in this trial
systemic non-biological treatments
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Physiological Effects of Drugs
Sponsors listed in this trial
Janssen Biotech, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers